md-anderson
(2)
PranaX
PranaX is a Houston-based regenerative medicine biotechnology company developing stem cell-derived exosome products to counter aging, inflammation, and tissue damage. Built on exosome technology exclusively licensed from The University of Texas MD Anderson Cancer Center, PranaX operates an FDA-registered cGMP facility at the Levit Green life science campus and is bringing to market a physician-directed exosome wellness supplement (ExoWELL) and a personal exosome banking service (ExoSTORE). The company closed an oversubscribed $17M Series A in early 2026.
Michael Prokopis
Michael Prokopis is the CEO of DARVIS, a Houston-based AI and computer vision company that gives hospitals real-time visibility into their inventory. A former Navy Surface Warfare Officer and Gulf War veteran turned healthcare supply chain executive, he spent 25+ years managing more than $3.2 billion in spend and driving $360M+ in savings at institutions including MD Anderson Cancer Center and Steward Health Care before crossing to the other side of the table to run the technology company he once wanted to buy from.